.Avidity Biosciences impressed investors along with stage 1/2 records in Duchenne muscular dystrophy...
.Actinogen Medical's cortisol blocker has missed the major endpoint of a period 2 research in clinic...
.Antibody-drug conjugates (ADCs) have actually gone to the center of several a billion-dollar biobuc...
.Resource manager TPG, which has actually assisted biotechs including Sionna Therapies and Santa Cla...
.Merck & Co.'s TIGIT system has actually experienced another setback. Months after shuttering a s...
.After a year described by pipeline cuts, the departure of its own CEO and cutbacks, Exscientia is g...
.Cullinan Therapy was excited enough with Harbour BioMed's bispecific invulnerable reactor that it e...
.In this week's episode of "The Leading Line," our experts're diving into Fierce Biotech's annual St...
.The confetti is still soaring from Eli Lilly's party celebrating the commendation of Alzheimer's di...
.Accept to this week's Chutes & Ladders, our summary of significant leadership hirings, firings a...